Lv11
30 积分 2021-08-09 加入
Targeting KRAS in cancer
1小时前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
5天前
已完结
Current perspectives of KRAS in non-small cell lung cancer
5天前
已完结
Phase 2 Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1C
1个月前
已完结
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study
1个月前
已完结
Clinical Outcomes in Patients With Krukenberg Tumors From Colorectal Cancer
1个月前
已完结
Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers
2个月前
已完结
Neurofibromatosis type 1
2个月前
已完结
Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family
2个月前
已完结
MET amplification as a potential therapeutic target against hepatocellular carcinoma
2个月前
已完结
皖公网安备34019202002308
